Dr. David Loeb: A Phase II Open Label Basket Trial Study Using Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Ewing's U
Written By Alana Arens

Dr. David Loeb (Children's Hospital at Montefiore) makes a repeat guest appearance to present and discuss an upcoming Phase II Clinical Trial centered around DFMO for Ewing sarcoma and Osteosarcoma (NCT07321912).

Alana Arens
Previous

Dr. Holly Meany: SABRE Trial - CAR-TA (B7-H3)
Next

Dr. Maggie Fader: Functional Precision Medicine Clinical Trial